Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
deals
2
×
genentech
2
×
life sciences
national blog main
national top stories
san francisco blog main
2
×
san francisco top stories
acetylon pharmaceuticals
ambys medicines
avapritinib
blueprint medicines
boston
cell therapy
clinical trials
constellation pharmaceuticals
cstone pharmaceuticals
eli lilly
european medicines agency
fda
fisogatinib
flatiron health
gene therapy
hepatocellular carcinoma
holger willenbring
investing
ipo
jeff albers
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
medullary thyroid cancer
new york blog main
new york top stories
non-small cell lung cancer
What
medicines
2
×
aiming
ambys
approval
big
biotech
blueprint
cancer
candidate
control
currently
deadly
deal
debuted
diseases
drug
fda
formed
future
launch
liver
make
marketing
muscle
new
pact
regulatory
ret
review
roche
startup
takeda
team
today
treatments
unusual
variety
wins
Language
unset
Current search:
deals
×
medicines
×
" san francisco blog main "
×
biotech
×
genentech
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?